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The ATR–Claspin–Chk1 pathway is critical for turning on the cellular
response to DNA damage and replication stress. Five recent reports
uncover new mechanisms controlling the recovery phase of the
checkpoint response, and introduce crucial roles for Claspin, Rad17
phosphorylation and the ubiquitin proteasome pathway in Chk1
signaling.Benjamin E. Gewurz
and J. Wade Harper
Proper duplication of
chromosomes is critical to cellular
function and organismal
development. Errors in this
process can result in altered
cellular pathways, aneuploidy, and
disease. Organisms have
consequently evolved elaborate
control mechanisms to ensure the
faithful transmission of their
genetic material [1].
Cells respond to DNA damage
and replication blocks by activating
the DNA-damage response
network, a system which arrests
the cell cycle and facilitates DNA
repair. The machinery that senses
damage and activates repair
systems has been well studied. In
contrast, far less is known about
how the damage signal is
terminated upon completion of
DNA repair. In a series of elegant
papers published recently in
Current Biology, Molecular Cell
and Cell [2–6], several groups have
uncovered important regulatory
mechanisms that govern activation
and turnover of Claspin — a critical
mediator of the DNA-damage
signaling system. Controlling
Claspin abundance through the
ubiquitin proteasome pathway
appears to be at the heart of
checkpoint recovery.Linking Rad17 to the ATR–
Claspin–Chk1 Signaling Complex
The DNA-damage response
pathway is composed of sensors,
mediators, signal transducers and
effectors [1]. However, because
sensors form complexes with
mediators and transducers, the
lines between these different
functionalities are somewhat
blurred. The ATR–ATRIP protein
kinase complex is a critical
component of the cellular response
to DNA damage and replication
blocks [7]. ATR–ATRIP associates
with single-stranded DNA at sites
of damage with the help of
replication protein A (RPA) and
thus functions as a sensor of
damage [8]. In concert, the Rad17
protein loads the DNA clamp
Rad9–Rad1–Hus1 onto chromatin
[9]. Rad17 binds chromatin
independently of ATR, but in
response to damage is
phosphorylated by ATR at two
sites (serine 635 and serine 645).
These events culminate in the
activation of Chk1 by ATR–ATRIP.
Although it was clear that
activation of Chk1 requires ATR,
Rad17 and the Chk1 associated
protein Claspin, the precise role of
Rad17 phosphorylation and the
relationship between Rad17 and
Claspin was largely unknown [10].
To address these questions,
Wang et al. [6] replaced cellularRad17 with a mutant form of
Rad17, Rad17AA, which is
defective in phosphorylation by
ATR–ATRIP. They found that,
although Rad17 phosphorylation is
not required for chromatin binding
or survival in culture, cells
expressing Rad17AA displayed
a shortened S-phase and
increased rates of spontaneous
chromosome breakage [6]. Rad17
phosphorylation was also found to
be necessary for cell survival in the
presence of hydroxyurea,
a ribonucleotide reductase
inhibitor and replication
checkpoint activator, but not for
survival after ultraviolet exposure.
Thus, distinct damage networks
differentially rely on Rad17
phosphorylation by ATR–ATRIP.
Chk1 is also required for cell
survival in the presence of
hydroxyurea, raising the question
of whether Rad17 phosphorylation
promotes Chk1 activation. Wang
et al. [6] showed that, in response
to hydroxyurea, Chk1 activation
was reduced and prematurely
terminated after hydroxyurea
removal in Rad17AA-expressing
cells. Interestingly, Claspin forms
a complex with Rad17 in a
manner that depends on
Rad17 phosphorylation.
Moreover, phosphorylation of
Claspin was also blocked in
Rad17AA-expressing cells.
Taken together, these data are
consistent with a model in which
ATR–ATRIP phosphorylation of
Rad17 promotes ATR
phosphorylation of Claspin,
possibly via a Claspin–Rad17
complex. This presumably
promotes Chk1 recruitment to
Claspin, and ultimately Chk1
activation by ATR. This model is
consistent with the observation
that Rad17 phosphorylation is
required to maintain Chk1
activation during the early periods
Dispatch
R933of recovery from hydroxyurea
treatment.
Claspin Degradation Turns
off the Checkpoint
Once damaged DNA has been
repaired, cells must turn off the
checkpoint and reenter the cell
cycle. The mechanisms of
checkpoint termination are poorly
understood, but three groups
[2,4,5] have now identified a central
role for the ubiquitin proteasome
pathway in controlling recovery
from the replication checkpoint,
with Claspin as the primary target.
Because replication stress likely
occurs even during unperterbed
cell cycles, it is not surprising that
this mechanism functions even in
the absence of exogenous
mutagens.
Two different approaches were
used to link Claspin to the ubiquitin
proteasome pathway. Peschiaroli
et al. [4] used a new proteomic-
based substrate–capture
approach to find novel targets of
the E3 ubiquitin ligase SCFb-TRCP.
This E3 has previously been
implicated in the control of multiple
cell-cycle events, through
ubiquitination of the negative
mitotic regulators Wee1 and Emi1,
and also of the positive cell-cycle
regulator Cdc25A [11]. In response
to DNA damage, Chk1 promotes
Cdc25A ubiquitination by
SCFb-TRCP [12,13]. Claspin was
found to associate with b-TRCP,
the substrate receptor of this E3 [4].
This association required
a canonical b-TRCP
phosphodegron (DpSGFXpS,
where F is a hydrophobic residue
and pS is phosphoserine) in the
Claspin amino terminus.
Taking an alternative approach,
Mailand et al. [5] and Mamely et al.
[2] examined whether, like Chk1,
Claspin levels might be cell cycle
regulated. Indeed, they found that
Claspin levels were high in
S-phase, and low during prophase,
mitosis and G1, paralleling the
establishedWee1 pattern. Through
the identification of a candidate
b-TRCP phosphodegron in
Claspin, Mailand et al. [5] and
Mamely et al. [2] were able to finger
SCFb-TRCP as a potential E3 for
Claspin. All three groups [2,4,5]
found that depletion of b-TRCP by
RNA interference stabilizedClaspin, and that phosphodegron
mutation stabilized Clapsin during
G2, when it is normally degraded.
Moreover, Claspin turnover either
in asynchronous cells or during
checkpoint recovery was blocked
by the proteasome inhibitor
MG132, implicating the ubiquitin
proteasome pathway [2,4,5].
What triggers Claspin
degradation, either in G2 or during
recovery from checkpoint arrest,
and how is this trigger regulated?
All three groups [2,4,5] identified
Plk1 as a kinase critical for Claspin
destruction, and Plk1was shown to
promote Claspin ubiquitination by
SCFb-TRCP in vitro [4,5]. Plk1 has
numerous roles during mitosis and
cytokinesis, and has recently been
shown to generate
phosphodegrons on b-TRCP
targets prior to mitotic entry
[11,14–16]. Degradation of these
proteins occurs during G2,
paralleling the pattern found for
Claspin. Indeed, previous studies
indicated that Plk1 is required for
recovery of cells from G2
DNA-damage arrest [17], and that
Plk1 is inhibited in response to
DNA damage [18], by an unknown
mechanism. Further studies are
required to understand how Plk1 is
activated during G2, and how it is
targeted to Claspin. Such events
may be prevented by Chk1, which
stabilizes Claspin during S-phase.
What are the consequences of
failing to turn off Claspin?
Expression of Claspin mutants
lacking the phosphodegron,
which can not be ubiquitinated by
b-TRCP, delays cell-cycle
resumption after DNA damage or
replication stress [2,4,5]. Stabilized
Claspin mutants delay cell-cycle
resumption because of the
resulting prolonged activation of
Chk1. Thus, destruction of Claspin
is a critical step in the disassembly
of the DNA-damage checkpoint
signaling network, at least in
human tissue culture cells. In
Xenopus, Plk1 promotes
dissociation of Claspin from
chromatin [19]. Further studies
are required to determine whether
the conserved b-TRCP
phosphodegron in Xenopus
Claspin is used to control its
turnover after chromatin release.
Likewise, it is unclear whether
MRC1 [20], the yeast version ofClaspin, is regulated similarly, as
yeast lack an obvious b-TRCP
ortholog and MRC1 does not
have a canonical b-TRCP
phosphodegron.
Buffering Claspin against
Premature Degradation
Given the critical role of Claspin
degradation in Chk1 inactivation,
the question arises as to how
cells prevent inappropriate Claspin
degradation. The answer may
lie in the identification of
a deubiquitinating enzyme, USP28,
which promotes removal of
ubiqutin chains from several
checkpoint proteins, including
Claspin [3]. USP28 was identified
as a protein associated with the
checkpoint mediator protein
53BP1. Disruption of USP28
function renders cells resistant to
ionizing radiation-induced
apoptosis. Analysis of a host of
checkpoint proteins revealed that
several, including Chk2 and
mediators such as Claspin, are
dramatically destabilized in the
absence of USP28 after DNA
damage, suggesting that USP28
normally protects these proteins
from degradation during
checkpoint activation. Claspin is
a bona fide USP28 substrate, as
Claspin deubiquitination by USP28
could also be reconstituted in vitro.
In response to ionizing radiation,
USP28 is phosphorylated in an
ATM-dependent manner,
potentially providing a mechanism
for control of USP28 activity [3].
Outstanding Questions
While this work provides new
insights into how signaling through
the ATR–Claspin–Chk1 pathway is
regulated, several questions
remain. Is Claspin the primary
protein whose destruction during
recovery allows for cell-cycle
progression? In this regard,
a number of checkpoint mediators
and regulators are unstable
proteins whose destruction may be
required for re-instating the
cell-cycle machinery. How is Plk1
activity controlled during S-phase
to ensure that Claspin is not
prematurely degraded? One
possibility is that Rad17 and/or
Chk1 sequesters Claspin, and
thereby blocks access to Plk1.
Alternatively, additional kinases
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Claspin for phosphorylation by
Plk1, although the finding that
Plk1 can promote SCFb-TRCP -
dependent ubiqutination of Claspin
in vitro may argue against this.
Understanding how Plk1 is
regulated during S-phase will be
necessary for distinguishing
between these possibilities.
Finally, the antagonistic
relationship between USP28 and
SCFb-TRCP with respect to
controlling Claspin levels may
signal a theme common to proteins
involved in cell-cycle transitions:
regulatory inputs into opposing
systems creates switch-like
behavior that governs cell-cycle
transitions.
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